agilon health, inc. Debt Securities, Available-for-sale, Unrealized Loss
agilon health, inc. (AGL) reported Debt Securities, Available-for-sale, Unrealized Loss of $5.24 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2022-11-03
- agilon health, inc. debt securities, available-for-sale, unrealized loss for the quarter ending 2022-09-30 was $5.10M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 6 month | Debt Securities, Available-for-sale, Unrealized Loss 9 month |
|---|---|---|---|
| 2022-09-30 | $5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.24M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $141.00K 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |